Federal grants to Ting Therapeutics, Inc.
Ting Therapeutics, Inc. in San Diego, California received $4.3 million in federal grants from fiscal 2021 to 2025, across 4 awards. Its largest program was Research Related to Deafness and Communication Disorders, with $4.0 million. In fiscal 2025 it was awarded $524,300.
From USAspending.gov award records, updated October 31, 2026.
- Grants, FY 2021 to 2025$4.3 million
- Awards4
- Awarded in FY 2025$524,300
- Largest award$1.5 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 0 | $0 |
| FY 2022 | 2 | $1.1 million |
| FY 2023 | 3 | $1.5 million |
| FY 2024 | 3 | $1.2 million |
| FY 2025 | 1 | $524,300 |
Programs that fund Ting Therapeutics, Inc.
| Program | Awards | Amount |
|---|---|---|
| Research Related to Deafness and Communication Disorders | 3 | $4.0 million |
| Military Medical Research and Development | 1 | $349,658 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 3 | $4.0 million |
| Department of Defense | 1 | $349,658 |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Preclinical evaluation of an otoprotectant TT002 - project summary ting therapeutics LLC is a pharmaceutical company developing drugs to prevent and treat hearing loss. Cisplatin is one of the most widely used drugs to treat cancers. However, cisplatin therapy causes hearing loss in 40-60% of the pa | Research Related to Deafness and Communication Disorders | July 26, 2022 | $1.5 million |
| CDK2 inhibitors for protecting hearing loss - CDK2 inhibitors for protecting hearing loss ting therapeutics LLC is a pharmaceutical company developing drugs to prevent and treat hearing loss. Cisplatin is one of the most widely used drugs to treat cancers. However cisplatin anticancer therapy causes | Research Related to Deafness and Communication Disorders | November 4, 2021 | $1.5 million |
| Therapeutics to prevent aminoglycoside-induced hearing loss - project summary ting therapeutics LLC is a pharmaceutical company developing drugs to prevent and treat hearing loss. Aminoglycosides are one of the most widely used drugs to treat gram-negative bacterial infections. However, aminoglycosi | Research Related to Deafness and Communication Disorders | July 17, 2024 | $1.0 million |
| Effect of afatinib against noise-induced hearing loss | Military Medical Research and Development | July 27, 2023 | $349,658 |
Questions people ask
How much federal grant money does Ting Therapeutics, Inc. get?
$4.3 million in 4 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Ting Therapeutics, Inc. the most?
The Department of Health and Human Services, with $4.0 million in 3 awards. The Department of Defense follow.
What is Ting Therapeutics, Inc.'s largest federal grant?
$1.5 million under Research Related to Deafness and Communication Disorders, with its first action in the period on July 26, 2022. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Ting Therapeutics, Inc.?
Its largest are Research Related to Deafness and Communication Disorders and Military Medical Research and Development.
Other grant recipients in San Diego
- San Diego Association of Governments
- Metropolitan Transit System
- General Atomics
- Neighborhood House Association
- San Diego County Regional Airport Authority
- San Diego State University Foundation
- San Diego Unified School District
- Family Health Centers of San Diego Inc
Largest federal grant recipients in California · Federal grants in California